New
StratifAI
The AI engine Fit Assessment
BetaThe company will be attending the 2024 Health Tech Forward Event
Blurb
Enhancing treatment decision-making with AI-driven precision oncology
HQ Location
Dresden (Germany)
Founded
2023
Employees
1 - 10
Total funding raised
$1.66M
Last Funding Event
Pre-Seed, $1.66M, September 2, 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Developer of multimodal artificial intelligence models intended to deliver prognostic insights from routinely available histology images and clinical data to guide treatment decisions in oncology. The company engages in advancing cancer treatment through expertise in biomarker discovery, clinical trial data analysis, large language models and information retrieval, and multimodal data integration, enabling pharmaceutical companies to develop personalized treatment for every cancer patient.